IDEAYA Biosciences (IDYA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on IDEAYA Biosciences (IDYA) is Neutral.

The composite score behind that read is -0.08, weighing +0.08 of bullish evidence against -0.31 bearish.

IDEAYA Biosciences last closed at $36.11, +0.14% on the session.

Against the IVW growth benchmark the position is -0.66% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

20 graded predictions for IDYA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks IDEAYA Biosciences in the 29th percentile on return on equity, where 100 is best.

IDEAYA Biosciences is classified under Health Care / Biotechnology, with a market capitalisation of $3.48B.

StockMap tracks IDEAYA Biosciences as the 63rd largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite IDEAYA Biosciences ranks 198th of 381 in the group, against a group median of -0.08.